[Translation] A randomized, double-blind, placebo-controlled Phase I clinical study to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of single and multiple topical administrations of AD101 ointment in Chinese healthy subjects and subjects with mild to moderate atopic dermatitis
评价中国健康受试者局部单次、多次给药AD101软膏后的安全性、耐受性和药代动力学特征;评价特应性皮炎受试者多次给药AD101软膏后的安全性、耐受性和药代动力学特征;初步评价局部多次AD101软膏治疗轻中度特应性皮炎的临床疗效。
[Translation] To evaluate the safety, tolerability, and pharmacokinetic characteristics of single and multiple topical administrations of AD101 ointment in healthy Chinese subjects; to evaluate the safety, tolerability, and pharmacokinetic characteristics of multiple topical administrations of AD101 ointment in subjects with atopic dermatitis; and to preliminarily evaluate the clinical efficacy of multiple topical administrations of AD101 ointment in the treatment of mild to moderate atopic dermatitis.